関連する実験動画
まとめ
継続的なヘパリン療法により,主要なタンパク質酶阻害体であるプラズマ抗トロビンIII (AT-III) が著しく減少します. この減少は,長期のヘパリン治療中に観察された血栓塞栓合併症を説明する可能性がある.
関連する概念動画
こちらも読む
関連記事
共著者、ジャーナル、引用グラフによってこの研究に関連する記事。
並び替え
Same author
Involvement of salsolinol in the suckling-induced oxytocin surge in sheep.
Domestic animal endocrinology·2016
Same author
Salsolinol-a potential inhibitor of the gonadotropic axis in sheep during lactation.
Domestic animal endocrinology·2016
Same author
Salsolinol Up-Regulates Oxytocin Expression and Release During Lactation in Sheep.
Journal of neuroendocrinology·2016
Same author
Interleukin-1 β Modulates Melatonin Secretion in Ovine Pineal Gland: Ex Vivo Study.
BioMed research international·2015
Same author
A2A adenosine receptor deletion is protective in a mouse model of Tauopathy.
Molecular psychiatry·2015
Same author
Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function.
Leukemia·2012
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026
Same journal
Dual mobility total hip replacement in fractures: stability promotes patient confidence.
Lancet (London, England)·2026